Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Details

Connection

Eric Simoes to Respiratory Syncytial Virus Infections

This is a "connection" page, showing publications Eric Simoes has written about Respiratory Syncytial Virus Infections.

 
Connection Strength
  
 
 
5.734
  
  1. Stensballe LG, Ravn H, Kristensen K, Meakins T, Aaby P, Simoes EA. Seasonal variation of maternally derived respiratory syncytial virus antibodies and association with infant hospitalizations for respiratory syncytial virus. J Pediatr. 2009 Feb; 154(2):296-8.
    View in: PubMed
    Score: 0.281
  2. Stensballe LG, Hjuler T, Andersen A, Kaltoft M, Ravn H, Aaby P, Simoes EA. Hospitalization for respiratory syncytial virus infection and invasive pneumococcal disease in Danish children aged <2 years: a population-based cohort study. Clin Infect Dis. 2008 Apr 15; 46(8):1165-71.
    View in: PubMed
    Score: 0.266
  3. Simoes EA, Groothuis JR, Carbonell-Estrany X, Rieger CH, Mitchell I, Fredrick LM, Kimpen JL. Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing. J Pediatr. 2007 Jul; 151(1):34-42, 42.e1.
    View in: PubMed
    Score: 0.252
  4. Choudhuri JA, Ogden LG, Ruttenber AJ, Thomas DS, Todd JK, Simoes EA. Effect of altitude on hospitalizations for respiratory syncytial virus infection. Pediatrics. 2006 Feb; 117(2):349-56.
    View in: PubMed
    Score: 0.228
  5. Leidy NK, Margolis MK, Marcin JP, Flynn JA, Frankel LR, Johnson S, Langkamp D, Simoes EA. The impact of severe respiratory syncytial virus on the child, caregiver, and family during hospitalization and recovery. Pediatrics. 2005 Jun; 115(6):1536-46.
    View in: PubMed
    Score: 0.218
  6. Simoes EA. Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. J Pediatr. 2003 Nov; 143(5 Suppl):S118-26.
    View in: PubMed
    Score: 0.195
  7. Ponnuraj EM, Springer J, Hayward AR, Wilson H, Simoes EA. Antibody-dependent enhancement, a possible mechanism in augmented pulmonary disease of respiratory syncytial virus in the Bonnet monkey model. J Infect Dis. 2003 Apr 15; 187(8):1257-63.
    View in: PubMed
    Score: 0.188
  8. Szefler SJ, Simoes EA. Montelukast for respiratory syncytial virus bronchiolitis: significant effect or provocative findings? Am J Respir Crit Care Med. 2003 Feb 01; 167(3):290-1.
    View in: PubMed
    Score: 0.186
  9. Simoes EA, Carbonell-Estrany X. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries. Pediatr Infect Dis J. 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20.
    View in: PubMed
    Score: 0.186
  10. Stensballe LG, Devasundaram JK, Simoes EA. Respiratory syncytial virus epidemics: the ups and downs of a seasonal virus. Pediatr Infect Dis J. 2003 Feb; 22(2 Suppl):S21-32.
    View in: PubMed
    Score: 0.186
  11. Piedimonte G, Simoes EA. Respiratory syncytial virus and subsequent asthma: one step closer to unravelling the Gordian knot? Eur Respir J. 2002 Sep; 20(3):515-7.
    View in: PubMed
    Score: 0.180
  12. Wenzel SE, Gibbs RL, Lehr MV, Simoes EA. Respiratory outcomes in high-risk children 7 to 10 years after prophylaxis with respiratory syncytial virus immune globulin. Am J Med. 2002 Jun 01; 112(8):627-33.
    View in: PubMed
    Score: 0.177
  13. Law BJ, Carbonell-Estrany X, Simoes EA. An update on respiratory syncytial virus epidemiology: a developed country perspective. Respir Med. 2002 Apr; 96 Suppl B:S1-7.
    View in: PubMed
    Score: 0.175
  14. Simoes EA, Groothuis JR. Respiratory syncytial virus prophylaxis--the story so far. Respir Med. 2002 Apr; 96 Suppl B:S15-24.
    View in: PubMed
    Score: 0.175
  15. Simoes EA. Immunoprophylaxis of respiratory syncytial virus: global experience. Respir Res. 2002; 3 Suppl 1:S26-33.
    View in: PubMed
    Score: 0.172
  16. Simoes EA, Tan DH, Ohlsson A, Sales V, Wang EE. Respiratory syncytial virus vaccine: a systematic overview with emphasis on respiratory syncytial virus subunit vaccines. Vaccine. 2001 Dec 12; 20(5-6):954-60.
    View in: PubMed
    Score: 0.171
  17. Ponnuraj EM, Hayward AR, Raj A, Wilson H, Simoes EAF. Increased replication of respiratory syncytial virus (RSV) in pulmonary infiltrates is associated with enhanced histopathological disease in bonnet monkeys (Macaca radiata) pre-immunized with a formalin-inactivated RSV vaccine. J Gen Virol. 2001 Nov; 82(Pt 11):2663-2674.
    View in: PubMed
    Score: 0.170
  18. Simoes EA. Overlap between respiratory syncytial virus infection and influenza. Lancet. 2001 Oct 27; 358(9291):1382-3.
    View in: PubMed
    Score: 0.170
  19. Kimpen JL, Simoes EA. Respiratory syncytial virus and reactive airway disease. New developments prompt a new review. Am J Respir Crit Care Med. 2001 Mar; 163(3 Pt 2):S1.
    View in: PubMed
    Score: 0.162
  20. Simoes EA. Treatment and prevention of respiratory syncytial virus lower respiratory tract infection. Long-term effects on respiratory outcomes. Am J Respir Crit Care Med. 2001 Mar; 163(3 Pt 2):S14-7.
    View in: PubMed
    Score: 0.162
  21. Howard TS, Hoffman LH, Stang PE, Simoes EA. Respiratory syncytial virus pneumonia in the hospital setting: length of stay, charges, and mortality. J Pediatr. 2000 Aug; 137(2):227-32.
    View in: PubMed
    Score: 0.156
  22. Simoes EA. Immunoprophylaxis of respiratory syncytial virus infection. Indian Pediatr. 2000 Mar; 37(3):243-7.
    View in: PubMed
    Score: 0.152
  23. Simoes EA. Respiratory syncytial virus and subsequent lower respiratory tract infections in developing countries: A new twist to an old virus. J Pediatr. 1999 Dec; 135(6):657-61.
    View in: PubMed
    Score: 0.149
  24. Simoes EA. Respiratory syncytial virus infection. Lancet. 1999 Sep 04; 354(9181):847-52.
    View in: PubMed
    Score: 0.146
  25. Canfield SD, Simoes EA. Prevention of respiratory syncytial virus (RSV) infection: RSV immune globulin intravenous and palivizumab. (American Academy of Pediatrics). Pediatr Ann. 1999 Aug; 28(8):507-14.
    View in: PubMed
    Score: 0.146
  26. Simoes EA, Hayward AR, Ponnuraj EM, Straumanis JP, Stenmark KR, Wilson HL, Babu PG. Respiratory syncytial virus infects the Bonnet monkey, Macaca radiata. Pediatr Dev Pathol. 1999 Jul-Aug; 2(4):316-26.
    View in: PubMed
    Score: 0.145
  27. Simoes EA, Sondheimer HM, Top FH, Meissner HC, Welliver RC, Kramer AA, Groothuis JR. Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease. The Cardiac Study Group. J Pediatr. 1998 Oct; 133(4):492-9.
    View in: PubMed
    Score: 0.137
  28. Babu PG, Selvan A, Christuraj S, David J, John TJ, Simoes EA. A primate model of respiratory syncytial virus infection. Indian J Exp Biol. 1998 Aug; 36(8):758-62.
    View in: PubMed
    Score: 0.136
  29. Madhi SA, Cutland CL, Downs S, Jones S, van Niekerk N, Simoes EAF, Nunes MC. Burden of Respiratory Syncytial Virus Infection in South African Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Pregnant and Postpartum Women: A Longitudinal Cohort Study. Clin Infect Dis. 2018 05 17; 66(11):1658-1665.
    View in: PubMed
    Score: 0.134
  30. Groothuis JR, King SJ, Hogerman DA, Paradiso PR, Simoes EA. Safety and immunogenicity of a purified F protein respiratory syncytial virus (PFP-2) vaccine in seropositive children with bronchopulmonary dysplasia. J Infect Dis. 1998 Feb; 177(2):467-9.
    View in: PubMed
    Score: 0.131
  31. Hall CB, Simoes EA, Anderson LJ. Clinical and epidemiologic features of respiratory syncytial virus. Curr Top Microbiol Immunol. 2013; 372:39-57.
    View in: PubMed
    Score: 0.092
  32. Yusuf S, Piedimonte G, Auais A, Demmler G, Krishnan S, Van Caeseele P, Singleton R, Broor S, Parveen S, Avendano L, Parra J, Chavez-Bueno S, Murgu?a De Sierra T, Simoes EA, Shaha S, Welliver R. The relationship of meteorological conditions to the epidemic activity of respiratory syncytial virus. Epidemiol Infect. 2007 Oct; 135(7):1077-90.
    View in: PubMed
    Score: 0.062
  33. Stensballe LG, Kristensen K, Simoes EA, Jensen H, Nielsen J, Benn CS, Aaby P. Atopic disposition, wheezing, and subsequent respiratory syncytial virus hospitalization in Danish children younger than 18 months: a nested case-control study. Pediatrics. 2006 Nov; 118(5):e1360-8.
    View in: PubMed
    Score: 0.060
  34. Meissner HC, Groothuis JR, Rodriguez WJ, Welliver RC, Hogg G, Gray PH, Loh R, Simoes EA, Sly P, Miller AK, Nichols AI, Jorkasky DK, Everitt DE, Thompson KA. Safety and pharmacokinetics of an intramuscular monoclonal antibody (SB 209763) against respiratory syncytial virus (RSV) in infants and young children at risk for severe RSV disease. Antimicrob Agents Chemother. 1999 May; 43(5):1183-8.
    View in: PubMed
    Score: 0.036
  35. Rodriguez WJ, Gruber WC, Groothuis JR, Simoes EA, Rosas AJ, Lepow M, Kramer A, Hemming V. Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy children. Pediatrics. 1997 Dec; 100(6):937-42.
    View in: PubMed
    Score: 0.032
  36. Rodriguez WJ, Gruber WC, Welliver RC, Groothuis JR, Simoes EA, Meissner HC, Hemming VG, Hall CB, Lepow ML, Rosas AJ, Robertsen C, Kramer AA. Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group. Pediatrics. 1997 Mar; 99(3):454-61.
    View in: PubMed
    Score: 0.031
  37. Simoes EA, Groothuis JR, Tristram DA, Allessi K, Lehr MV, Siber GR, Welliver RC. Respiratory syncytial virus-enriched globulin for the prevention of acute otitis media in high risk children. J Pediatr. 1996 Aug; 129(2):214-9.
    View in: PubMed
    Score: 0.030
  38. Groothuis JR, Simoes EA, Hemming VG. Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG). Respiratory Syncytial Virus Immune Globulin Study Group. Pediatrics. 1995 Apr; 95(4):463-7.
    View in: PubMed
    Score: 0.027
  39. Groothuis JR, Simoes EA, Levin MJ, Hall CB, Long CE, Rodriguez WJ, Arrobio J, Meissner HC, Fulton DR, Welliver RC, et al. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N Engl J Med. 1993 Nov 18; 329(21):1524-30.
    View in: PubMed
    Score: 0.025
  40. Groothuis JR, Simoes EA, Lehr MV, Kramer AA, Hemming VG, Rodriguez WJ, Arrobio J, Welliver RC, Siber GR. Safety and bioequivalency of three formulations of respiratory syncytial virus-enriched immunoglobulin. Antimicrob Agents Chemother. 1995 Mar; 39(3):668-71.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)